Sound waves, no scalpel: Li Ka-shing extends cancer therapy to kidney tumours
What it is about
Who published it, and when
How it spread - 2 original reports
Wed, 11 November 2026
2 reports- South China Morning Post05:02first to report
Hong Kong will become the first city in Asia to conduct clinical trials of a non-invasive treatment for kidney tumours, extending the technology beyond liver and pancreatic cancers, with tycoon Li Ka-shing funding places for 30 patients across three private hospitals. The Li Ka Shing Foundation announced on Wednesday that CUHK Medical Centre, Gleneagles Hospital Hong Kong and the Hong Kong Sanatorium & Hospital would launch the trials using histotripsy, a technology that uses focused sound...
- South China Morning Post09:30
Hong Kong is expanding clinical trials of histotripsy, a non-invasive treatment that uses focused ultrasound to destroy tumours, as the city seeks to establish a role in developing the technology for kidney cancer. The CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital would begin trials involving 30 patients targeting kidney cancer, the Li Ka Shing Foundation said on Wednesday. The trials mark the latest development in Hong Kong business tycoon Li...